Galbraith Daniel

Galbraith Daniel sold 39,207 shares (91.1% of holdings) at $40.00 on 2025-05-13 for $1,568,280; stock down 30.7% from 52-week high.

Galbraith Daniel executed a substantial liquidation of his BWIN position, selling 39,207 shares (-91.1% vs pre-transaction holdings) for $1,568,280.00, reducing his stake to 3,849 shares. The transaction occurred at $40.00 per share; since then the stock has declined to $38.30, down 30.7% from its 52-week high of $55.29 and down 11.8% over the past 30 days. His cross-ticker track record shows 7 prior sales with an average 90-day return of +2.2% and a well-timed rate of 14.29%, indicating mixed execution; his prior BWIN sale on 2024-08-29 achieved a 90-day return of +5.2% but was not well-timed at the 90-day mark. The company reported $413.4M quarterly revenue with +14.0% annual growth but was unprofitable over its most recent full fiscal year, creating a backdrop where a near-complete exit by this insider warrants investor attention to whether he perceives deteriorating fundamentals or value realization.

Galbraith Daniel sold 75,000 shares of BWIN at $46.33 for $3.5M on 2024-08-29; stock near 52-week high

Galbraith Daniel sold 75,000 shares at $46.33, with the current price at $46.89 near the 52-week high of $46.89. The company has grown revenue 24.2% year-over-year but remains unprofitable with a net loss of $17.6M in its latest full fiscal year, creating a structural mismatch between growth and earnings. The stock has gained 39.2% over the past 90 days and 7.2% over the past 30 days. Notably, the filing contains a derivative-conversion transaction (Table II derivative securities not yet populated in the database), meaning the insider retains derivative holdings beyond the 75,000 common shares sold; this is not a complete exit from economic exposure. The insider's historical cross-ticker track record shows a 16.67% well-timed rate on prior sells, suggesting limited predictive accuracy on individual sale decisions.